Lexicon Pharmaceuticals Inc LXRX

US Pharmaceuticals

$1.88 ▼ -1.05% ($-0.02)

Open $1.92

Prev Close $1.90

Day Range $1.80 – $1.94

52W Range $1.10 – $2.68

Market Cap $836.52M

Beta 1.05

EPS (TTM) $-0.15

📋 Company Profile

Industry	Pharmaceuticals
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2000-04-07
Shares Out.	444,200,000
Website	lexpharma.com/ ↗
Phone	12818633000
Employees	81
Revenue	$692,000
Gross Profit	$653,000
Net Income	-$31.8M
Free Cash Flow	-$65.0M
Total Assets	$250.1M
Total Liabilities	$75.5M
Equity	$174.5M

About Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Lexicon Pharmaceuticals Inc is a publicly traded company under the ticker symbol LXRX on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.